Novavax vax 90% effective against Covid infections

eAwaz Medicine

New York – Novavax’s Covid-19 vaccine is 90 per cent effective at preventing Covid-19 illness, the company said after Phase 3 clinical trials. Thus it has the same efficacy as the mRNA vaccines produced by Pfizer-BioNTech and Moderna. The company is still seeking full licensure from the Food and Drug Administration. Novavax is taking steps before applying for the regulatory authorizations it will need to start rolling out its vaccine.